Methamphetamine withdrawal and the restoration of cognitive functions – a study over a course of 6 months abstinence

•Long-term MA intake was identified as indicator of poorer cognitive performance.•declines in general neurophysiological functioning with ongoing years of consumption.•declines in attention/ concentration with ongoing years of consumption.•regain of cognitrone and cognitive flexibility after 6 month...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychiatry research 2019-11, Vol.281, p.112599-112599, Article 112599
Hauptverfasser: Proebstl, Lisa, Krause, Daniela, Kamp, Felicia, Hager, Laura, Manz, Kirsi, Schacht-Jablonowsky, Maik, Straif, Maximilian, Riebschläger, Marlies, Neumann, Stefanie, Schreiber, Anne, Soyka, Michael, Koller, Gabi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•Long-term MA intake was identified as indicator of poorer cognitive performance.•declines in general neurophysiological functioning with ongoing years of consumption.•declines in attention/ concentration with ongoing years of consumption.•regain of cognitrone and cognitive flexibility after 6 months abstinence. A continuously rising consumption of methamphetamine (MA) has been suggested to be associated with increasing cognitive dysfunction. The objective of this study was to investigate associations between cognitive functions and gender, drug using patterns and treatment-attending profiles of recently abstinent MA users over the course of six months abstinence. Data were collected from 108 participants in two inpatient rehabilitation centers. The mean duration of MA use was 11.5 years. Interviews and cognitive tests (cognitrone, Stroop, TMT, nback) were performed right after the withdrawal and again after approx. six months of abstinence. Comparisons and explorative analyses between the groups (gender, primary MA/ multidrug users, early dropouts/ completers) regarding cognitive variables were performed. At baseline a significant decline in general neuropsychological functioning and attention/concentration after ongoing years of consumption were found. After a period of six months abstinence, cognitive performances remained stable or improved significantly for cognitrone percentile and cognitive flexibility. Normal cognitive functions were measured in former MA users after acute withdrawal which remained stable and partly improved in those patients who refrained from substance abuse over six months. Continued long-term MA intake was the only identified indicator of poorer cognitive performance. These results point towards a regain of cognitive performance in patients abstinent from MA.
ISSN:0165-1781
1872-7123
DOI:10.1016/j.psychres.2019.112599